NDC 14783-159-01 - LBEL CONCENTRE TOTAL LABIOS GLOBAL PERFECTION SPF 20 ROUGE AMORE/Red
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 14783-159
- Requested NDC
- 14783-159-01
- Package NDCs from labels
- 14783-159-01, 14783-159-02
- Manufacturer
- Ventura International LTD | Bel Star S.A. (Colombia)
- Effective date
- 2020-11-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OCTINOXATE and ZINC OXIDE - Ventura International LTD | Bel Star S.A. (Colombia) | Ventura International LTD | Bel Star S.A. (Colombia) | 2020-11-16 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 14783-159-02 | 2025-05-16 | C162847 | 48780-1 | 9d75b9d0-5083-f424-e053-dadaa90a57ce | L'BEL CONCENTRÉ TOTAL LABIOS LIPSTICK GLOBAL PERFECTION SPF 20 |
| 14783-159-02 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-5083-f424-e053-dadaa90a57ce | L'BEL CONCENTRÉ TOTAL LABIOS LIPSTICK GLOBAL PERFECTION SPF 20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.